Infection of the CD45RA+ (naive) subset of peripheral CD8+ lymphocytes by human immunodeficiency virus type 1 in vivo by McBreen, S et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Infection of the CD45RA+ (naive) subset of peripheral CD8+
lymphocytes by human immunodeficiency virus type 1 in vivo
Citation for published version:
McBreen, S, Imlach, S, Shirafuji, T, Scott, GR, Leen, C, Bell, JE & Simmonds, P 2001, 'Infection of the
CD45RA+ (naive) subset of peripheral CD8+ lymphocytes by human immunodeficiency virus type 1 in vivo'
Journal of Virology, vol. 75, no. 9, pp. 4091-102. DOI: 10.1128/JVI.75.9.4091-4102.2001
Digital Object Identifier (DOI):
10.1128/JVI.75.9.4091-4102.2001
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Journal of Virology
Publisher Rights Statement:
Copyright © 2001, American Society for Microbiology
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
JOURNAL OF VIROLOGY,
0022-538X/01/$04.0010 DOI: 10.1128/JVI.75.9.4091–4102.2001
May 2001, p. 4091–4102 Vol. 75, No. 9
Copyright © 2001, American Society for Microbiology. All Rights Reserved.
Infection of the CD45RA1 (Naive) Subset of Peripheral CD81
Lymphocytes by Human Immunodeficiency
Virus Type 1 In Vivo
S. MCBREEN,1 S. IMLACH,1 T. SHIRAFUJI,1 G. R. SCOTT,2 C. LEEN,3 J. E. BELL,4 AND P. SIMMONDS1*
Laboratory for Clinical and Molecular Virology, University of Edinburgh, Edinburgh EH9 1QH,1 Department of
Genitourinary Medicine, Royal Infirmary of Edinburgh, Edinburgh EH3 9YW,2 and Regional Infectious Diseases Unit3
and Department of Neuropathology,4 Western General Hospital, Edinburgh EH4 2XU, United Kingdom
Received 18 September 2000/Accepted 24 January 2001
To investigate the mechanism and functional significance of infection of CD81 lymphocytes by human
immunodeficiency virus type 1 (HIV-1) in vivo, we determined frequencies of infection, proviral conformation,
and genetic relationships between HIV-1 variants infecting naive (CD45RA1) and memory (CD45RO1)
peripheral blood CD41 and CD81 lymphocytes. Infection of CD31 CD81 CD45RA1 cells was detected in 9 of
16 study subjects at frequencies ranging from 30 to 1,400 proviral copies/106 cells, more frequently than CD31
CD81 lymphocytes expressing the RO isoform of CD45 (n 5 2, 70 and 260 copies /106 cells). In agreement with
previous studies, there was no evidence for a similar preferential infection of CD41 naive lymphocytes. Proviral
sequences in both CD41 and CD81 lymphocyte subsets were complete, as assessed by quantitation using
primers from the long terminal repeat region spanning the tRNA primer binding site. In six of the seven study
subjects investigated, variants infecting CD81 lymphocytes were partially or completely genetically distinct in
the V3 region from those recovered from CD41 lymphocytes and showed a greater degree of compartmental-
ization than observed between naive and memory subsets of CD41 lymphocytes. In two study subjects, arginine
substitutions at position 306, associated with use of the chemokine coreceptor CXCR4, were preferentially
found in CD4 lymphocytes. These population differences may have originated through different times of
infection rather than necessarily indicating a difference in their biological properties. The preferential distri-
bution of HIV-1 in naive CD81 lymphocytes indeed suggests that infection occurred early in T-lymphocyte
ontogeny, such as during maturation in the thymus. Destruction of cells destined to become CD81 lymphocytes
may be a major factor in the decline in CD81 lymphocyte frequencies and function on disease progression and
may contribute directly to the observed immunodeficiency in AIDS.
CD41 lymphocytes are considered to be the principal target
of human immunodeficiency virus type 1 (HIV-1), but more
recently a number of studies have shown the in vivo infection
of other lymphoid cell types including CD81 T lymphocytes
(12, 21, 31, 33, 51). CD81 T cells are a major immunological
defence against HIV-1 infection. In most individuals, HIV
mediates a strong specific cytotoxic activity that eliminates
productively infected cells. This response also blocks intracel-
lular viral replication in CD4 cells by production and secretion
of a number of soluble inhibitory factors such as macrophage
inflammatory proteins 1a and 1b and RANTES (regulated
upon activation, normal T-cell expressed and secreted), inter-
leukin-16, and other, as yet unidentified factors (17, 32). Dur-
ing the course of infection, there is a gradual loss of CD4 cells;
after an initial increase in the number of cytotoxic T cells, the
CD8 cell number similarly falls during disease progression
(29). The observed decline in both the number of CD8 cells
and specific HIV cytotoxic activity coincides with an increase in
viral load and may ultimately be a contributory factor to the
eventual collapse of the immune system and the development
of AIDS.
The mechanisms leading to CD8 T-cell dysfunction and de-
pletion are still unclear. CD8 T-cell function may be the indi-
rectly influenced by a defective HIV-1-specific CD4 T helper
response that is necessary for the maturation and function of
cytotoxic T cells. It has also been demonstrated after antigenic
stimulation some CD8 T cells develop a state of unresponsive-
ness and eventual death is mediated via apoptosis (19, 30).
However, it has been observed that productive HIV-1 infection
of cytotoxic T lymphocytes in vitro and in vivo in animal mod-
els can occur (47). The peripheral interaction between CD4
and CD8 cells occurring in vivo as part of the immune response
may allow direct transmission of infection to the CD8 lympho-
cytes. Alternatively, it is possible that damage to or deficiency
of the thymus may also confer direct infection. HIV-1 may
infect and destroy both intrathymic T progenitor cells (CD32
CD41 CD82), double-positive thymocytes (CD31 CD41
CD81) (4, 49) and mature CD3hi CD81 thymocytes (28). Re-
cent studies alternatively suggest that infection of CD8 lym-
phocytes may occur by a conventional CD4-dependent mech-
anism, as CD4 expression is up-regulated following activation
through the T-cell receptor complex (12, 49, 51).
Information on the mechanisms of CD8 lymphocyte infec-
tion can be obtained by analysis of relative frequencies of
infection of CD8 lymphocytes expressing the CD45RA (naive)
and CD45RO (memory/effector) isoforms, as has been previ-
ously described for CD4 lymphocyte infection (36). Abortive
or noncytopathic infection of double-positive (CD41 CD81)
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thymocytes during maturation in the thymus would produce
differentiated, naive CD81 lymphocytes in the circulation that
contained stably integrated HIV proviral sequences. However,
if infection occurred during the phase of CD4 expression after
antigenic stimulation of CD8 lymphocytes, then proviral se-
quences would be preferentially distributed in the memory/
effector population, as the activation process would result in a
change of phenotype from CD45RA1 to CD45RO1. In this
study, we investigated the frequency of HIV infection in CD4
and CD8 naive and memory cell populations separated from
peripheral blood mononuclear cells (PBMCs) of HIV-seropos-
itive individuals by quantitative PCR for HIV-1 proviral se-
quences. We also investigated possible genetic differences be-
tween variants of HIV-1 isolated from each of the lymphocyte
subsets that might relate to time of infection or determine
differences in cellular tropism.
MATERIALS AND METHODS
Samples and clinical details of study patients. Samples (20 to 30 ml) of whole
blood anticoagulated with EDTA were collected from seropositive individuals
attending the genitourinary medicine clinic or the infectious disease unit in
Edinburgh. CD4 counts, viral load information, and risk groups from the patient
group in whom distribution of HIV in naive and memory subsets of CD4 and
CD8 lymphocytes were analyzed (Table 1). Plasma virus loads were determined
by a commercially available PCR (Roche Monitor, Lewes, East Sussex, United
Kingdom). Further samples were collected from five healthy, HIV-seronegative
control for cell purity measurements.
Cell separations. Blood samples were diluted with an equal volume of phos-
phate-buffered saline and PBMCs were isolated by density centrifugation over a
Ficoll-Hypaque gradient (Lymphoprep; Nycomed). T lymphocytes were purified
from PBMCs using a negative selection pan-T isolation kit on an automated
MACS cell sorter (Miltenyi Biotec). CD81 and CD41 lymphocytes were isolated
from the purified T cells by positive selection using CD8- and CD4-conjugated
MACS beads. Naive and memory subsets of CD4 and CD8 lymphocytes were
separated from PBMCs by initial separation into CD41 and CD81 lymphocytes
by negative selection (Miltenyi Biotec). Naive and memory subsets of isolated
CD4 and CD8 lymphocytes by obtained by positive selection using CD45RA- and
CD45RO-conjugated MACS beads.
Analysis of the purity of isolated subsets by flow cytometry. For analyses in this
report, the following combinations of labeled monoclonal antibodies were used
(10 ml per 105 cells; 30 min at 4°C): (i) fluorescein isothiocyanate isomer 1
(FITC)-conjugated CD8, phycoerythrin (PE)-conjugated CD3, and phyco-
erythrin-Cy5 (Cy5)-conjugated CD4; (ii) FITC-CD45RA and PE-CD45RO; (iii)
FITC-CD45RA, PE-CD45RO, and Cy5-CD4; (iv) FITC-CD45RO, PE-CD45RA,
and Cy5-CD4; (v) FITC-CD45RA, PE-CD45RO, and Cy5-CD8; and (vi) FITC-
CD45RO, PE-CD45RA, and Cy5-CD8 (DAKO, Glostrup, Denmark). Cells
were washed twice in phosphate-buffered saline with 2% bovine serum albumin
and fixed in 200 ml of 2% formalin. The purity of the isolated CD41 CD45RA1,
CD41 CD45RO1, CD81 CD45RA1, and CD81 CD45RO1 cell populations
was assessed on a Coulter Epics Elite after gating on lymphocytes based on their
forward and side scatter characteristics. Each analysis was based on a minimum
of 5,000 events.
Detection and quantitation of HIV sequences. DNA was extracted from iso-
lated cell subsets as previously described (44). HIV proviral sequences were
quantified by limiting-dilution nested PCR (44, 54) using nested sets of highly
conserved PCR primers from the long terminal repeat (LTR) region. Pan-LTR
primers were 59-GRAACCCACTGCTTAASSCTCAA-39 (outer, sense) 59-TG
TTCGGGCGCCACTGCTAGAGA-39 (outer, antisense), 59-CTCAATAAAGC
TTGCCTTGAG-39 (inner, sense), and 59-GAGGGATCTCTAGNYACCAGA
GT-39 (inner, antisense) (59 base positions 506, 626, 524, and 578, respectively, in
the HXB2 genome). Complete LTR (C-LTR) primers were 59-ACTCTGGT
RNCTAGAGATCCCTC-39 (outer, sense), 59-GGCGTACTCACCAGTCG
CCG-39 (outer, antisense), 59-TCTCTAGCAGTGGCGCCCGAAC-39 (inner,
sense), and 59-TCAGCAAGCCGAGTCCTG-39 (inner, antisense) (59 base po-
sitions 578, 735, 626, and 692, respectively, in the HXB2 genome). Both primary
and secondary PCRs for pan-LTR and C-LTR primers were carried out using the
following parameters: 94°C for 18 s, 55°C for 21 s, and 72°C for 1.5 min for 30
cycles, followed by a final extension step of 72°C for 6 min. PCR amplicons were
run at 150 V for 30 min on 2% agarose gels containing 0.5 mg of ethidium
bromide/ml and visualized under UV light.
Quantification was performed by limiting-dilution PCR as previously de-
scribed (44). Nucleotide sequences from the V3 region (patient samples p2, p3,
p4, p11, p13, p14, and p15) were amplified using previously described primers
(24, 40, 43). To serve as negative controls, parallel separations, extractions, and
amplifications were carried out with PBMCs isolated from buffy coats leukocytes
derived from HIV-negative blood. HIV-1 DNA could be detected in CD4 T
lymphocytes and CD8 T lymphocytes from HIV-seropositive individuals but not
in any negative controls.
Cloning of the PCR products. Amplified DNA was ligated into a plasmid
vector prior to nucleotide sequencing using the pGEM-T vector system (Pro-
TABLE 1. Clinical profile and frequencies of infection of naive and memory subsets of CD4 and CD8 T lymphocytes.
Study
subject Sex
a Risk groupb Viral load(genome eq/ml)
CD4
count (ml)
Proviral copies/106 cells
CD41 lymphocytes CD8
1 CD45RA1
(naive) cells
CD81 CD45RO1
(memory) cells
CD45RA1 CD45RO1 Proviralload
CD4
contaminationc
Proviral
load
CD4
contamination
p1 F IDU 14,000 10 98 834 ,10 0.9 ,10 11
p2 M MH 514,500 29 1,106 587 107 10 (9.4) ,10 8.0
p3 M MH 116,000 74 133 278 1,444 1.2 (0.1) ,10 3.8
p4 M MH 18,000 130 596 4,272 ,10 5.4 ,10 58
p5 M MH ,400 232 686 457 422 6.2 (1.5) 67 6.2 (17)
p6 F Het 52,000 265 866 1,566 ,10 7.9 ,10 21
p7 M IDU/Het 48,000 267 95 520 ,10 0.9 ,10 7.1
p8 M IDU 460,000 280 4,307 2,137 22 39 (180) 259 29 (21)
p9 M MH .750,000 282 575 2,321 40 5.2 (13) ,10 32
p10 M MH 81,540 301 1,307 464 622 12 (1.9) ,10 6.3
p11 M MH 661,000 311 834 3,916 ,10 7.6 20 53 (270)
p12 F IDU 64,680 329 55 115 ,10 0.5 ,10 1.6
p13 M MH 67,980 354 115 222 71 1.0 (1.5) ,10 3.0
p14 F Het ,513 360 533 980 119 4.9 (4.1) ,10 13
p15 M MH 60,589 748 653 Negative 31 5.9 (19) ,10 ,0.1
p16 M MH 1,680 850 143 25 ,10 1.3 ,10 0.3
a F, female; M, male.
b Abbreviations: IDU, injecting drug user; MH, male homosexual; Het, infection acquired through heterosexual contact.
c Estimated contribution of contaminating CD4 cells to proviral load (percent of total) detected in CD8 lymphocytes, using mean purity data from controls (Table 4).
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mega, Southampton, United Kingdom). The ligated product was transformed
into competent cells (JM109; Promega) and plated on Luria-Bertani plates (200
mg of ampicillin/ml). The plasmid DNA was denatured by incubation with 1/10
volume of 2 M sodium hydroxide–2 mM EDTA at 37°C for 30 min. DNA was
precipitated by addition of 1/10 volume of 3 M sodium acetate and 2 volumes of
ethanol and incubation at 220°C overnight.
Nucleotide sequencing and analysis. Dideoxynucleotide sequencing was car-
ried out with a U.S. Biochemical Sequenase 2.0 kit (Amersham Life Science,
Piscataway, N.J.) with [35S]dATP, and patient plasma samples were sequenced
using a Thermosequenase radiolabeled terminator cycle sequencing kit accord-
ing to the manufacturer’s instructions.
Sequences were aligned and distances were estimated using the Simmonic
2000 sequence editor package. Phylogenetic analysis was carried out using the
MEGA program (27). The nucleotide sequences from V1/V2 and V3 amplified
from each of the study subjects were compared with each other and with a range
of standard HIV-1 variants. Each set of sequences from the four study subjects
was monophyletic in both genomic regions and distinct from those of the pub-
lished sequences of subtype B: HIVSF2 (K02007), HIVRF (M17451), HIVOYI
(M26727), HIVLAI (K02013), HIVJRFL (M74978), HIVYU2 (M93258),
HIVCAM1 (D10112), HIVNY5CG (M38431), HIVHAN (U43131), HIVWMJ22
(M12507), and HIVSFAAA (M65024).
Nucleotide sequence accession numbers. Nucleotide sequences obtained in
this study have been submitted to GenBank and assigned accession numbers
AF353734 through AF353941.
RESULTS
Detection of HIV proviral sequences in CD8 lymphocytes. T
lymphocytes were separated from PBMCs by negative selec-
tion using immobilized magnetic beads. Fluorescence-acti-
vated cell sorting analysis showed substantial purity of the
separated T cells, with $94% of cells coexpressing CD3 and
CD45 (mean, 97.4%) (Table 2). Monocyte contamination, de-
tected by the expression of CD14 and CD45, was minimal
(,3%; mean, 1.1%). Purified CD31 lymphocytes were subse-
quently separated by positive selection for CD8 expression
and, in a separate step carried on the remaining cells, for CD4.
Analysis of the purity of selected CD8 lymphocytes revealed
extremely low numbers of contaminating CD4 lymphocytes
(Table 2; Fig. 1), in no case exceeding 0.5% of the total pop-
ulation. Knowledge of this frequency combined with quantita-
tion of proviral load in purified CD8 and CD4 lymphocytes
allowed calculation in worst-case situations (i.e., 0.5% CD4
contamination) of the contribution of CD4 lymphocytes to the
proviral load detected in CD8 lymphocytes (see below).
Having established the effectiveness of the cell separation
method, we separated samples from seven HIV-infected indi-
viduals into CD4 and CD8 T lymphocytes and assayed them for
HIV proviral DNA sequences using highly conserved primers
from the LTR. These pan-LTR primers amplify DNA se-
quences immediately downstream from the tRNA primer bind-
ing site and are therefore potentially able to detect incomplete
transcripts resulting from abortively infected cells (18, 52).
Frequencies of infected cells ranged from 30 to 670 proviral
copies/106 CD4 lymphocytes and from 8 to 500 /106 CD8 lym-
phocytes. The worst-case scenario, where CD4 lymphocytes
comprise 0.5% of the CD8 population (see above), failed to
account for the proviral sequences detected in CD8 lympho-
cytes in at least five of the seven samples (Table 3; Fig. 2A).
Maximum contributions from contaminating CD4 lymphocytes
ranged from ,5% in these four samples and 27 and 33% in the
remaining two. These latter samples contained low proviral
loads in the CD8 lymphocyte subset (,10 copies/106 cells).
Similar results were obtained on retesting proviral loads using
a different set of primers (C-LTR) (Table 3). In this case, CD4
contamination accounted for #1% of proviral load detected in
five samples and for 16 and 44% in the remaining two).
Detection of complete proviral transcripts. To determine
whether proviral sequences detected in CD4 and CD8 lympho-
cytes were incomplete or complete transcripts, DNA samples
from each subset were quantified using a second set of primers
spanning the region on either side of the primer binding site.
Quantitation of the plasmid HXB2 demonstrated that pan-
LTR and C-LTR primers had equal sensitivities (data not
shown), and so the detection of greater proviral loads using the
pan-LTR primers in CD4 or CD8 lymphocytes would indicate
the presence of incomplete proviral transcripts. Proviral loads
using the two sets of primers were comparable in each case,
with no evidence for higher virus loads detected with the pan-
LTR primers (median ratio of pan-LTR to C-LTR, 0.638; Z 5
0.76 using Wilcoxon signed rank test; P 5 0.445 [not signifi-
cant]).
Distribution of HIV in naive and memory subsets of CD4
and CD8 lymphocytes. To obtain phenotypically unchanged
CD41 and CD81 T lymphocytes for separation of naive and
memory subsets, it was necessary to use negative selection to
isolate CD4 and CD8 lymphocytes prior to positive selection
with CD45RA and CD45RO monoclonal antibodies. The
purity of the isolated CD41 CD45RA1, CD41 CD45RO1,
CD81 CD45RA1, and CD81 CD45RO1 cell populations
from five HIV-1-negative individuals and one HIV-1-positive
individual was determined (Table 4). CD41 lymphocytes con-
tained 0.9 to 1.3% contaminating CD81 cells, similar to that
found in the sample from the HIV-positive sample (0.7 to
1.2%). Contamination of the separated CD81 lymphocytes by
CD41 cells was similarly low (0.8 to 1.7%). As described above
for CD4 and CD8 lymphocytes separated by positive selection,
the contribution of contaminating CD41 lymphocytes could
not account for the proviral load detected in the majority if
CD8 lymphocytes samples (see below).
HIV sequences in DNA from each of the purified lympho-
cyte subsets of the 16 study subjects was quantified by limiting
dilution (Table 1; Fig. 2B and C). HIV-1 proviral DNA was
detected in the CD4 naive and CD4 memory subsets of all
patients studied (between 55 and 4,307 provirus copies per 106
cells) except in the CD4 memory subset of p15 (Table 1). The
frequency of infection and proportion of virus load contributed
TABLE 2. Purity of isolated pan-T and CD81 lymphocytes
Sample
T lymphocytes CD8 lymphocytes
%
CD41 CD451
%
CD31 CD451
%
CD41 CD82
%
CD31 CD81
HIV negative
1 2.6 98.1 0.2 99.0
2 0.5 96.4 0.2 98.2
3 0.1 99.8 0.3 96.0
4 0.1 96.7 0.4 97.3
Mean 0.6 98.2 0.3 97.3
HIV positive
1 2.5 94.0 0.4 97.2
2 1.3 98.0 0.5 99.0
3 0.7 99.0 0.5 96.4
Mean 1.5 97.0 0.4 97.5
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by naive and memory subsets of CD4 lymphocytes varied with
absolute CD4 count. CD4 naive lymphocytes contributed the
majority of infected cells in those with high CD4 counts (r 5
0.703, P 5 0.02), while memory cells were predominantly in-
fected in individuals with low CD4 counts (r 5 20.450, P 5
0.08).
HIV DNA was also detected in nine samples of separated
CD81 CD45RA1 lymphocytes, and in three CD81 CD45RO1
subsets from 10 of the 16 individuals. The contribution of
contaminating CD4 lymphocytes to the measured virus loads
was small or insignificant in 10 of these samples (Table 1), and
these were considered to represent infection of CD8 lympho-
cytes. In eight individuals, HIV preferentially infected the na-
ive subset of CD8 T lymphocytes, with proviral frequencies
ranging from 25 to and 1,440 provirus copies per 106 cells).
There was a tendency for higher frequencies of infected CD81
FIG. 1. Analysis by three-color flow cytometry of CD8 lymphocytes purified by positive selection from PBMCs of three HIV-positive (1ve)
individuals. Cells were labeled with monoclonal antibodies to CD3 (PE), CD8 (FITC), and CD4 (Cy5).
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CD45RA1 cells to be found in individuals with lower CD4
counts, although this difference did not reach statistical signif-
icance (P 5 0.286). Frequencies of HIV-infected CD8 lympho-
cytes did not correlate with disease status, risk group, antiviral
therapy, or total CD4 lymphocyte counts. There was no corre-
lation between frequency of infection of CD8 cells with either
CD4 subset.
Effect of antiviral therapy on CD4 and CD8 lymphocyte
infection. CD4 and CD8 naive and memory lymphocyte sub-
sets were separated from pretreatment and sequential post-
treatment samples collected from five individuals receiving
combination antiviral treatment and then analyzed for proviral
sequences (Table 5). Treated individuals showed rises in cir-
culating CD4 counts and reductions in circulating viremia.
Despite the effectiveness of the antiviral therapy, the distribu-
tion and frequency of infected cells in each of the subsets
remained relatively stable, in all cases remaining within a 61-
log10 range of the levels detected in the initial samples. Infec-
tion of CD8 lymphocytes remained detectable in the three
individuals whose first samples were positive, while the two
individuals with negative CD8 lymphocytes in the pretreatment
samples remained negative during treatment. There was evi-
dence for a decline in the frequency of infected CD41
CD45RA1 and CD41 CD45RO1 lymphocytes over the course
of treatment (r 5 20.428; P 5 0.098 and r 5 0.545; P 5 0.029
respectively). A similar decrease in the frequencies of infected
CD81 CD45RA1 cells was not observed, although fewer ob-
servations were made (r 5 0.070; P 5 0.870).
Sequence comparison of HIV infecting different lymphocyte
subsets. To investigate the possible genetic partitioning and
differences in predicted phenotype of HIV infecting CD4 and
CD8 lymphocytes, proviral sequences of the V3 hypervariable
region of env were compared (Fig. 3 and 4). From seven study
subjects, approximately 10 clones derived from amplified DNA
extracted from the separated lymphocyte subsets were se-
quenced. The combined set of V3 sequences from each indi-
vidual were monophyletic and distinct from those of previously
published V3 region sequences (data not shown).
Sequence diversity within lymphocyte subsets and the degree
of partitioning between them varied considerably between the
study subjects. V3 sequences from the naive CD4 and CD8
subsets of p15 grouped together and showed mean diversities
of 0.002 to 0.0064, similar to the mean pairwise distance be-
tween subsets (0.0071). In marked contrast, sequences from
CD8 lymphocytes of p14 were distinct from all other cell types,
forming a separate clade supported in 100% of bootstrap re-
samplings. In this individual, the mean pairwise distance be-
tween the CD8 and CD4 lymphocytes ranged from 0.113
(CD41 CD45RA1) to 0.119 (CD41 CD45RO1), much greater
than the diversity within the CD8 population (0.0076). There
was no correlation between sequence diversity in any of the
subsets with disease progression, nor was there correlation
with proviral load (data not shown).
Among the six study subjects from whom CD8 lymphocyte
sequences were obtained, five showed either partial or com-
plete separation from CD4 virus populations. In contrast, only
one of six study subjects showed any evidence for separation of
CD4 naive and memory subsets (p8) (Fig. 4). Most sequences
contained neutral or acidic residues at positions 306 and 320.
However, sequences of certain subsets of lymphocytes from p8
(CD41 CD45RA1) and p14 (CD41 lymphocytes and plasma)
contained arginine residues at position 306 along with several
other amino acid changes in V3 and flanking regions. These
sequences formed phylogenetically distinct clades that grouped
separately from variants found in other subsets.
DISCUSSION
The use of magnetic bead separation provides an effective
method to isolate subsets of lymphocytes that can be assayed
for HIV infection by conventional PCR. One of the problems
with the technique when used to investigate infection of CD8
TABLE 3. Frequencies of infection of CD4 and CD8 lymphocytes and contribution of contaminating CD4 lymphocytes
to the proviral load detected in CD8 lymphocytes
Study subject CD4 (proviral copies/106 CD4 lymphocytes)
Proviral contaminationa CD8 (proviral copies/
106 CD8 lymphocytes)
% Mean (range)
CD4 contributionbMinimum Mean Maximum
Pan-T LTR primers
p17 215 0.41 0.73 1.01 101 0.72 (0.40–1.00)
p18 309 0.59 1.05 1.45 23 4.55 (2.55–6.31)
p19 672 1.28 2.28 3.16 56 4.07 (2.28–5.64)
p20 579 1.10 1.96 2.72 10 19.6 (11.0–27.2)
p21 30 0.06 0.10 0.14 19 0.53 (0.30–0.74)
p22 563 1.07 1.91 2.65 8 23.8 (13.4–33.1)
p23 551 1.05 1.87 2.59 499 0.37 (0.21–0.52)
C-LTR primers
p17 216 0.41 0.73 1.01 505 0.14 (0.08–0.20)
p18 514 0.98 1.74 2.42 585 0.30 (0.17–0.41)
p19 52 0.10 0.18 0.24 56 0.31 (0.31–0.44)
p20 901 1.71 3.05 4.23 9.6 31.82 (17.8–44.1)
p21 63 0.12 0.21 0.30 29 0.74 (0.41–1.02)
p22 271 0.51 0.92 1.27 8 11.48 (6.4–15.92)
a Contribution of CD4 lymphocytes to proviral load detected in CD8 lymphocyte subset, corresponding to minimum (0.19%), mean (0.34%), and maximum (0.47%)
contamination levels observed in control experiments (Table 2), expressed as copies per 106 cells.
b Percentage of proviral load in CD8 lymphocyte subset attributable to CD4 contamination.
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lymphocytes is the possibility that even low-level contamina-
tion by CD4 lymphocytes may produce false positive results.
To verify that CD8 lymphocytes were infected, we combined
purity measurements with calculations of the contribution to
proviral load of contaminating CD4 lymphocytes. Using posi-
tive selection methods to isolate CD4 and CD8 lymphocytes,
we demonstrated that CD4 contamination could not account
for the proviral load detected in the separated CD8 lympho-
FIG. 2. Comparison of net proviral load in CD4 and CD8 lymphocytes separated by positive selection (A), and in CD4 lymphocytes (B) and
CD8 lymphocytes (C) separated by negative selection, followed by positive selection for CD45RA and CD45RO.
TABLE 4. CD3, CD4, and CD8 expression on isolated CD41 CD45RA1, CD41 CD45RO1, CD81 CD45RA1,
and CD81 CD45RO1 lymphocytesa
Sample
CD3 expression (%) CD4 expression (%) CD8 expression (%)
CD41
RA1
CD41
RO1
CD81
RA1
CD81
RO1
CD41
RA1
CD41
RO1
CD81
RA1
CD81
RO1
CD41
RA1
CD41
RO1
CD81
RA1
CD81
RO1
HIV negative
1 79.1 98.7 98.7 68.5 73.4 93.9 2.5 2.4 2.3 1.9 93.1 60.9
2 97.2 93.8 99.2 97.6 95.6 90.9 0.4 1.3 0.6 0.3 98.4 97.5
3 98.9 99.9 98.4 91.8 96.1 97.1 0.9 2.6 1.6 1.3 92.6 79.2
4 99.4 99.2 88.4 96.8 95.2 96.5 0.1 0.3 0 0 84.2 91.0
5 99.2 97.6 88.8 50.2 98.1 95.3 0 0 1.7 0 80.9 45.6
Mean 97.6 97.6 94.7 81.0 91.7 86.5 7 1.6 1.3 0.9 83.3 70.1
HIV positive 94.8 97.8 94.5 92.8 95.1 94.7 0.8 1.3 1.2 0.7 89.8 78.8
a RA1 and RO1, CD45RA1 and CD45RO1.
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cytes from at least five of the seven samples tested (Table 3). A
similar conclusion was drawn from comparison of frequencies
of infected CD45RA1 and CD45RO1 CD8 lymphocytes with
measurements of CD4 contamination (Table 1). The purity of
T cells isolated by the pan-T negative selection method and in
particular the lack of significant monocyte contamination (Ta-
ble 2) provided evidence against a significant contribution to
proviral load by other cell types in the PBMC population.
Further evidence was provided by lack of a correlation be-
tween frequencies of infected CD4 lymphocytes and detection
of proviral sequences in either the CD31, CD81, CD81
CD45RA1 or CD31, CD81, CD81 CD45RO1 populations
(Tables 1 and 3). For example, the sample with the highest
frequency of infected CD4 lymphocytes (p4) contained unde-
tectable frequencies of CD8 infection; similarly, the sample
with the highest CD8 proviral load contained relative low fre-
quencies of infection of both subsets of CD4 cells. Third,
although there was considerable intersubject variability in the
detection of CD8 lymphocyte infection, longitudinal sampling
of the same individual over time revealed remarkable stabil-
ity in proviral loads in each of the lymphocyte subsets. For
example, pretreatment samples from p1 and p12 contained
undetectable frequencies of infected CD8 lymphocytes, while
samples subsequently remained negative. The remaining indi-
viduals with infected CD8 lymphocytes pretreatment remained
PCR positive subsequently. The consistency of provirus detec-
tion in the lymphocyte subset argues against sporadic contam-
ination by CD4 lymphocytes as a reason for our observations.
Finally, CD4 contamination would not account for the fre-
quent genetic differences observed in the V3 hypervariable
regions between variants recovered from CD8 with those from
the CD45RA1 and CD45RO1 subpopulations of CD4 lym-
phocytes (Fig. 3).
In this study, expression of the RA and RO isoforms of
CD45 was used to select between two functionally different
subsets of T lymphocytes (naive and memory /effector, respec-
tively) in the peripheral circulation. The separation method
had to be modified to avoid potential cellular activation and
resulting change in CD45 expression that may occur during the
two rounds of positive selection required by the original meth-
od (positive selection for CD8 or CD4, followed by bead re-
moval and positive selection by CD45RA or CD45RO mono-
clonal antibodies). Evidence for the effectiveness of the second
method is provided by the similarity in the combined frequen-
cies of infected CD45RA1 and CD45RO1 CD8 and CD4 cells
with those measured in CD8 and CD4 lymphocytes separated
by positive selection in this (Fig. 2) and previous (31) studies.
It is unlikely that CD8 lymphocytes were significantly contam-
inated with CD4 lymphocytes with Nef-induced down-regula-
tion of CD4 expression. It has been long established that the
proportion of provirus-positive PBMCs that are actively in-
fected with HIV is extremely low. PBMCs expressing HIV
mRNAs detectable by in situ hybridization were undetectable
or present only at very low frequencies (16), frequencies con-
siderably adrift from the numbers of PBMCs containing pro-
viral DNA sequences (42, 44). More recently, quantitative
PCR methods to detect multiply spliced mRNA transcripts
(from which nef is translated) have been developed. They have
confirmed that few, if any, cells in the peripheral circulation
contain transcriptionally active HIV (2). In a variety of HIV-
infected individuals, frequencies of multiply spliced mRNA
ranged from 0 to 700 copies per 2 3 105 PBMCs. As a pro-
ductively infected cell expresses at least 100 to 1,000 spliced
transcripts, the expression detected in vivo can be accounted
for by a few or even single virus-expressing cells in the sample.
These frequencies are considerably adrift from the numbers of
provirus-positive cells detected in the CD8 fraction purified by
negative selection (Table 1).
TABLE 5. Infection of lymphocyte subsets of study subjects receiving combination antiviral therapy
Patient Therapya
Time (days)
since start of
treatment
CD4
count/ml
Circulating plasma
virus load (genome
eq of RNA/ml)b
Proviral copies/106 cells
CD41 CD81
CD45RA1 CD45RO1 CD45RA1 CD45RO1
p1 Pre 0 10 14,000 98 834 Neg Neg
1 27 150 1,700 34 239 Neg Neg
p9 Pre 0 283 750,000 575 2,321 40 Neg
1 48 3,000 72 1,807 215 Neg
p10 Pre 0 301 81,540
1 49 7 Neg 1,307 464 622 Neg
1 62 466 Neg 533 533 697 Neg
1 100 Neg 878 364 1,049 Neg
1 115 6 667 577 2,764 Neg
1 154 428 6 1,498 1,390 489 Neg
Stop 360 349 16,000 734 2,884 435 Neg
p12 Pre 0 329 64,680 55 115 Neg Neg
1 14 477 Neg 15 188 Neg Neg
1 41 540 Neg 19 119 Neg Neg
1 100 442 Neg 9 48 Neg Neg
1 340 207 Neg 18 56 Neg Neg
p14 Pre 0 360 Neg 533 980 119 Neg
1 27 418 Neg 158 1,307 203 Neg
1 153 465 Neg 351 183 144 Neg
a Combination treatment over study period. Pre, sample collected pretreatment (tested in Table 1); 1, sample affected while on treatment; stop, treatment stopped
because of side effects.
b Neg, ,400 genome eq/ml; 6, equivocal result.
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FIG. 3. Phylogenetic analysis of V3 region sequences from different lymphocyte subsets of seven study subjects. Symbols: F, CD81 CD45RA1
(naive) cells; E, CD41 CD45RA1 cells; n , CD81 CD45RO1 cells; h, CD41 CD45RO1 cells; < , cDNA sequences from plasma (p14). Trees were
rooted using the HIV-1MN sequence; a scale bar indicated at the bottom. Clades with .70% bootstrap supported are indicated by numbers on
branches.
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Quantitation of proviral sequences in these two subsets in-
dicated that the CD45RA1 (naive) subset was infected with
HIV-1 in vivo, in contrast to the distribution of proviral se-
quences in the RO and RA subsets of CD41 lymphocytes.
Separate identification of HIV-1 infection in naive and mem-
ory/effector cells provides information on the time of infection
of T cells relative to maturation and activation, which in turn
provides indirect information on the likely mechanisms under-
lying infection of peripheral CD8 lymphocytes. While expres-
sion of CD45RA and CD45RO has been the most commonly
used method for separating naive and memory/effector cells,
expression of other markers in combination with CD45 has
been used to more strictly define functionally distinct subsets.
Markers of cellular activation such as CD38 expression and
down-regulation of CD27 and CD28 have been used to identify
effector from memory and naive CD81 lymphocytes (8, 14, 15,
20, 35). Expression of CD62L in combination with CD45RA
has been used to define purer populations of naive CD4 cells,
as there is evidence that a proportion of memory CD4 cells of
HIV-positive individuals express CD45RA (36, 39). Whether
abnormal expression of CD45RA on the CD8 lymphocytes of
HIV-positive lymphocytes also occurs has not been deter-
mined. Recently it has been reported that the isoform of CD45
expressed on memory cells may ultimately revert to RA, po-
tentially producing a subset of CD45RA1 cells functionally
distinct from the naive phenotype (3).
While it is possible that a proportion of the CD45RA1 CD4
and CD8 populations analyzed in our study may have originally
been memory cells, the predominance of HIV-1 infection in
the CD8 CD45RA1 subset argues empirically that the main
FIG. 3—Continued.
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target CD8 lymphocyte is the naive subpopulation. For exam-
ple, it is unlikely that the infected CD8 cells detected are
memory revertants, as it would be likely that a similar fre-
quency of nonrevertant CD45RO1 lymphocytes would also be
infected.
Infection of naive cells has been documented extensively in
CD4 lymphocytes (36, 41, 45) and is confirmed in this study,
although in contrast to our findings, frequencies of infected
CD45RA1 have been reported to be lower than in the
CD45RO1 effector/memory population. The latter cells are
considered to be the main contributors to the pool of infected
lymphocytes in vivo, where cellular activation on antigenic
stimulation produces cells susceptible to infection and destruc-
tion by HIV-1 (9, 11, 48, 52, 53). Indeed, productive infection
of naive CD4 lymphocytes in vitro by laboratory isolates of
HIV-1 is demonstrably inefficient, most likely through lack of
T-cell activation necessary for efficient reverse transcription
and integration of the HIV genome after entry (9, 11, 39, 46,
48, 52, 53), and because they do not express the CCR5 che-
mokine coreceptor required for the entry of primary (non-
syncytium-inducing) variants (5, 34). Hypotheses developed to
account for the infection of naive CD4 lymphocytes may also
be relevant for the infection of naive CD8 lymphocytes in vivo
reported here.
There are several potential mechanisms for the infection of
CD8 lymphocytes, although most would not predict the pref-
erential distribution of infection in the naive subset. Peripheral
CD8 lymphocytes express low levels of CD4 on mitogenic and
antigenic stimulation in vitro, and it has been hypothesized
that this allows productive infection of CD8 lymphocytes in
vivo to occur (12, 25, 51). This hypothesis is supported by our
recent finding that CD4 expression can be detected on the
CD691, activated subpopulation of CD8 lymphocytes in PB-
MCs of both HIV-negative and HIV-positive individuals (S.
Imlach et al., unpublished data), but the requirement for cel-
lular activation suggests that the CD45RO1 population would
be the main reservoir of infected CD8 lymphocytes. The ab-
sence of any measurable excess of incomplete proviral tran-
scripts in CD8 lymphocytes (Table 3) provides further evi-
dence against active infection of this subset.
It is possible that genetic variants of HIV-1 evolve during
persistent infection to infect cells by a non-CD4-dependent
mechanism; high levels of virus replication and extensive de-
pletion of the CD4 target population may contribute to this
switch. While phenotypic characterization of HIV variants in-
fecting CD4 and CD8 lymphocytes would clearly be of value,
and the genetic differences observed in V3 provide evidence
for a genetic difference between the CD4 and CD8 popu-
lations, CD4-independent infection would likely remain cell
cycle-dependent, or perhaps become more so if based on ex-
pression of high levels of coreceptors, and again would pref-
erentially target the memory/effector CD8 cell population.
HIV-1 infection of CD41 CD81 immature thymocytes des-
tined to become CD8 lymphocytes during thymic maturation
(26, 28) would provide both a plausible mechanistic explana-
tion for their infection, and would also explain the presence of
proviral sequences in the naive subsets of both CD4 and CD8
lymphocytes in peripheral blood. The thymus represents a ma-
FIG. 4. Consensus V3 and flanking region sequences of lymphocyte subsets from seven study subjects. Separate consensus sequences were
calculated for the two phylogenetic groupings of CD8 sequences from p3 and p8. Amino acid residues are numbered according to HIV-1HXB2;
positions 306 and 320 are indicated; basic residues are indicated in bold. Symbols: ., sequence identity with HIV-1MN; ?, variable sites without 75%
majority consensus residue.
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jor target for HIV-1 infection in vivo, and destruction of thy-
mopoietic areas is observed on autopsy examination of AIDS
cases. Destruction of CD8 precursor cells would also explain
the eventual failure of CD8 homeostasis and decline in circu-
lating numbers of first naive and then memory CD8 lympho-
cytes on disease progression (37, 38), as well as the recovery in
numbers of naive CD81 (and CD41) lymphocytes generally
observed after commencement of antiviral treatment (1, 6).
Without biopsy material, it was not possible to directly observe
the replication of HIV within thymocytes. Indeed, proviral
sequences in naive cells in peripheral blood can be detected
only in circumstances where thymocytes survive infection with
HIV and mature into CD4 and CD8 lymphocytes. Survival of
infected cells may occur because the infecting virus was defec-
tive or because the provirus integrated into a site in the host
chromosome that prevented transcription. As documented for
naive CD4 lymphocytes in the peripheral circulation, where
frequencies of provirus-positive cells were approximately 100-
fold greater than infectivity titers (36), it is likely that the vast
majority of integrated proviral sequences detected in naive
CD8 lymphocytes would also be defective. The presence of
culturable virus from this subset therefore provides little infor-
mation on the degree of CD8 destruction that occurs in the
thymus.
Evidence for the quiescent nature of HIV-1 infection in CD8
naive lymphocytes, consistent with thymic infection, is pro-
vided by the observation of equivalence in proviral load in CD8
lymphocytes between the pan-LTR and C-LTR primers (Table
3), indicating that HIV proviruses were complete and poten-
tially stably integrated into the cellular genome. Second, we
observed a great stability in frequencies of infected CD8 pop-
ulation on antiretroviral therapy; combination treatment
achieved a complete clearance of circulating viremia in the
majority of study subjects (Table 5), while over the period of
virus suppression ranging from 1 to 11 months, there was no
consistent reduction in frequencies of infected CD8 lympho-
cytes. Over the same period, frequencies of infected naive and
memory subsets of CD4 lymphocytes showed a modest decline,
consistent with previous kinetic studies reporting half-lives of
proviral sequences from 21 to 58 weeks (7, 22, 23, 50).
Sequences recovered from the CD8 lymphocytes were fre-
quently distinct from those from CD4 lymphocytes, whereas
the CD45RA1 and CD45RO1 subsets of the latter were gen-
erally undifferentiated from each other. Although there was
great individual variation in the sequence relationships be-
tween different cell types, CD8 lymphocytes of p14 retained V3
sequences that lacked positively charged amino acid residues
associated with a CXCR4-dependent phenotype (10, 13), when
both subsets of CD4 lymphocytes and the plasma population
contained variants with arginine residues at these sites and
which were likely to have replaced the original population.
This indicates a slower turnover of the CD8 population in this
individual. Similar differences in rates of cell turnover may
therefore underlie the genetic differences between CD4 and
CD8 lymphocytes in other study subjects.
In summary, the evidence for infection of the CD45RA1
population of peripheral CD8 lymphocytes provides the basis
for testing a number of competing theories for the mechanism
CD8 lymphocyte infection in vivo. In the future, phenotypic
characterization of variants infecting the two cell types should
indicate whether CD4-independent entry of HIV-1 can occur.
Further studies on the turnover of HIV-1-infected CD8 lym-
phocytes in vivo, such as the acquisition of antiviral resistance
during treatment relapse, will provide information on the dy-
namics and consequences of CD8 infection and potentially on
the mechanisms underlying the loss of CD8 lymphocytes on
disease progression.
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